MITA cites progress in the final Medicare coverage decision for beta amyloid PET, expresses disappointment in its narrow scope

Written on:October 4, 2013
Comments are closed

The Medical Imaging & Technology Alliance (MITA) has issued the following statement in response to the Centers for Medicare & Medicaid Services’ (CMS) final decision to cover beta amyloid positron emission tomography (PET) imaging under coverage with evidence development (CED) for patients enrolled in an approved clinical study…

Source: Medical Devices


Sorry, the comment form is closed at this time.